CIAM
ROIV icon

Caitong International Asset Management’s Roivant Sciences ROIV Stock Holding History

Caitong International Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,081
Closed -$362K – 3387
2026
Q1 		$362K Buy
+13,081
New +$336K 0.07% 243
2025
Q3 		– Sell
-59
Closed -$665 – 2425
2025
Q2 		$665 Sell
59
-8
-12% -$87 ﹤0.01% 1656
2025
Q1 		$676 Sell
67
-4,257
-98% -$46K ﹤0.01% 1685
2024
Q4 		$51.2K Buy
+4,324
New +$51.1K 0.05% 475

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Caitong International Asset Management's ROIV Position: Q2 2026 in Review

Caitong International Asset Management sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 13,081 shares — an estimated $362K sold.

Caitong International Asset Management first reported a position in ROIV in Q4 2024 and held it in 4 quarters. The position peaked at $362K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Caitong International Asset Management reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 13,081 Roivant Sciences shares in Q2 2026, an estimated $362K.
  • Caitong International Asset Management first reported a position in Roivant Sciences in Q4 2024 and held it in 4 quarters.
  • Caitong International Asset Management's Roivant Sciences position peaked at $362K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.